Significant changes have taken place in the market structure of traditional Chinese medicinal materials

Speaking of China's "Four Major Medicine Capitals", Bozhou in Anhui, Anguo in Hebei, Zhangshu in Jiangxi, and Yuzhou in Henan are the areas with the highest recognition in history.
These areas are basically located in major transportation routes or river ports
.
However, since the beginning of the 21st century, with the acceleration of the docking of production and demand, the market structure of traditional Chinese medicinal materials has also undergone major changes
.
Traditional layout is difficult to adapt to the development of the times.
In 1996, the State Administration of Traditional Chinese Medicine, the former Ministry of Health, and the former State Administration for Industry and Commerce identified 17 specialized Chinese medicinal material markets, namely Bozhou in Anhui, Yuzhou in Henan, Hehuachi in Chengdu, and Hebei Anguo, Jiangxi Zhangshu, Guangzhou Qingping, Juncheng County Shunwang City, Chongqing Jiefang Road, Harbin Three Trees, Lanzhou Yellow River Medicine City, Xi’an Wanshou Road, Qizhou, Hubei, Hunan Yueyang Huabanqiao (later moved to Changsha), Hunan Shaodong, Guangxi Yulin, Guangdong Puning and Kunming Chrysanthemum Garden
.
It should be said that the main consideration at the time was historical inheritance factors without considering the abundance of surrounding resources, so the layout was unreasonable
.
By querying Tiandi Yuntu's big data platform for the pharmaceutical industry (hereinafter referred to as the big data platform), the author's statistical analysis of 17 domestic Chinese herbal medicine professional market operating entities shows that in terms of the number of entities, as of the end of 2020, Anhui Bozhou is still the largest market.
There are 8984; followed by Hebei Anguo, Chengdu Lotus Pond, Kunming Chrysanthemum Garden and Guangzhou Qingping; and Changsha Huabanqiao, Lanzhou Yellow River, Chongqing Jiefang Road and Harbin Sankeshu Market, whose market size has shrunk greatly because of being far away from the production area
.
It can be seen that, judging by the number of practitioners, Bozhou in Anhui, Anguo in Hebei, Lotus Pond in Chengdu and Chrysanthemum Garden in Kunming have more advantages in scale
.
From the perspective of transaction scale, according to the big data calculation of the annual traffic and transaction volume of connected trucks in 2020, Bozhou in Anhui, Qingping in Guangzhou, Anguo in Hebei and Yulin in Guangxi rank in the top four
.
It is understood that due to the rapid development of the precious medicinal materials and condiment food industry, many wholesale markets such as Ruyifang, Shanhai Market, Huangqi Market and Traditional Chinese Medicine Port have been formed around Qingping, Guangzhou.
The transaction volume is far ahead.
The big data platform shows that its 2020 The annual transaction amount is over 14.
2 billion yuan
.
Guangxi Yulin, supported by seasonings and medicinal materials imported from Southeast Asia, will also have a transaction volume of more than 10 billion yuan in 2020.
On the contrary, the Bozhou market, due to the lack of precious medicinal materials, trades a large number of medicinal materials mainly in low- and medium-priced varieties.
Only about 8.
4 billion yuan, slightly higher than the Chengdu lotus pond market; as Chengdu is the largest domestic cordyceps trading market, Puning is the largest western participating labor and trading market in China, and the transaction volume is far ahead of the Anguo market
.
It is not difficult to see that in terms of transaction volume, Guangzhou Qingping, Guangxi Yulin, Anhui Bozhou and Chengdu Hehuachi are ahead of other domestic medicinal material markets
.
Based on the comparison of the above dimensions and the comprehensive evaluation of market brand influence, the author believes that the new "four major pharmaceutical capitals" in China should be Bozhou in Anhui, Qingping in Guangzhou, Yulin in Guangxi, and Anguo in Hebei
.
The transformation and upgrading of the traditional market has accelerated in the past 10 years, the transformation and upgrading of the domestic traditional Chinese medicinal material market has been significantly accelerated, mainly focusing on the following three directions: one is the continuous transfer of market vendors to the place of production to achieve industrial transformation; the other is the wholesale and retail function of the traditional market Transformation; The third is the digital transformation of traditional markets
.
Vendors in traditional markets are moving towards the origin of the market and the integration of production and sales has accelerated.
Purchasers have bypassed the market and entered the medicinal material production areas.
The operators of the medicinal material markets such as Bozhou, Anhui and Anguo, Hebei have quickly changed from market operators to producers of origin
.
Taking Bozhou as an example, the big data platform shows that as of the end of 2020, there are 8,994 suppliers of traditional Chinese medicinal materials in Bozhou, but there are 43,569 local cooperatives and bases in Bozhou, ranking first among prefecture-level cities in the country; they are scattered in various production areas across the country.
The number of Bozhou suppliers that have established bases is as many as 76,432, also ranking first in the country
.
It can even be said that Bozhou Chinese medicinal materials suppliers have structured the traditional circulation pattern of Chinese medicinal materials across the country (see the figure for details)
.
Wholesale and retail has become the way to survive in the urban market.
It is understood that Guangzhou Qingping and Guangxi Yulin have used expensive medicinal materials and condiments to promote the transformation of traditional markets, forming a cluster of surrounding medicinal and food products and condiments.

.
Even small markets with less than 300 business households, such as Lanzhou Yellow River Pharmaceutical City, Chongqing Jiefang Road, and Harbin Sankeshu, have already turned into wholesale and retail markets for traditional Chinese medicine and nourishing ingredients relying on local urban consumers
.
Relying on the market of origin, the traditional Chinese medicinal material trade is completing digital transformation.
It is understood that as of the end of 2020, there have been 88 Chinese medicinal material storage and logistics bases in the country, basically relying on the traditional medicinal material market or the concentrated production area of ​​Chinese medicinal materials.
So far, the layout of the warehouse logistics base has taken shape.

.
New e-commerce platforms for Chinese medicinal materials and decoction pieces are also being built.
Although the actual effect remains to be seen, it also provides new ideas for the transformation and upgrading of the traditional medicinal material market
.
The author believes that the traditional Chinese medicinal material market, which has a history of over a thousand years, will not disappear in the short term.
It will only grow in another way and become an important part of the domestic Chinese medicinal material commodity circulation
.
The rapid development of e-commerce According to the monitoring data of the Guangdong Institute of Chinese Medicine and the big data platform, the online retail sales of pharmaceuticals in 2020 will be 151.
2 billion yuan, a growth rate of 59.
12%
.
It can be seen that the e-commerce platform has become an important drug sales terminal
.
Among them, Chinese patent medicines accounted for 26.
38%, Chinese medicine decoction pieces accounted for 6.
73%, and health foods accounted for about 9.
24%
.
From a practical point of view, there are three main forms of pharmaceutical e-commerce that are relatively successful: one is traditional pharmaceutical companies, especially online channels expanded by OTC companies; second, leading e-commerce or new e-commerce platforms are moving to the field of pharmaceutical e-commerce; third, taking a foothold Origin, develop C2C (individual sellers to individual consumers) e-commerce services
.
(This article is excerpted from the "2020 Domestic Chinese Medicinal Materials Industry Development Report" jointly compiled by the Tiandi Yuntu Pharmaceutical Industry Big Data Center and the Planting and Breeding Professional Committee of the Chinese Medicine Association)